Objectives: The study aims to explore the economic outcomes of the clinical pharmacist at critical care units at a private hospital in Riyadh city, Saudi Arabia in a 6 month study and prevent additional medication costs. Methods: It was a 6-months cross-sectional study from January to June 2016 in adults critical care unit. It was a thirty-bed critical care bed consisting of trauma, medical, surgical and maternity critical care cases. The pharmacist monitored all patients through daily medical round and documents any pharmacist intervention. The pharmacist intervention system used an international study model, measure level of activity, rational of clinical intervention, recommendation, patient outcome and pharmacoeconomic impact related estimated cost avoidance. Results: The total number of pharmacist interventions were (1,222) provided to (1,124) patients. The complete cost avoidance from pharmacist intervention over the study period was (220,882.10 UD) while over one year was (441,764.2 USD). The highest cost avoidance of critical care interventions was from potentially significant 51.00% (102,581.78 USD) and potentially serious 32.28% (99,162.29 USD). The majority of cost avoidance came from anti-infective agents (73,408.95 USD) followed by nutrition and blood agents (61,182.97 USD) and cardiovascular medications (27,584.52 USD). The most rational clinical activities cost avoidance was from others type (102,168.44 USD) followed by inappropriate dose (30,504.16 USD) and TPN consultations (25,313.99 USD). The most patient outcome related to cost avoidance was patient condition improved (120,036.38 USD) followed by unknown outcomes (47,067.85 USD) and laboratory values improved (21,661.55 USD). The most pharmacoeconomic cost avoidance impact was a reduction in the cost drug therapy 79.94% (163,747.96 USD) and the patient length of hospital stay decreased 1.15% (32,846.49 USD). Conclusion: The critical care clinical pharmacist prevent the additional cost of drugrelated problems occurrences and economic burden on the healthcare system at a private hospital in the Kingdom of Saudi Arabia. Expanding clinical pharmacist at critical care services is highly recommended to all private hospitals in Saudi Arabia.
Medical Group (HMG) of Hospitals is one of the largest private chains of hospitals in the Kingdom of Saudi Arabia. At HMG, the clinical pharmacy services were started in 2015 which provides services to the acute and chronic cases of neonates, pediatrics and adults. In this study, we aimed to explore the clinical and economic outcomes of providing clinical pharmacy services at critical care units at a private hospital in Riyadh City, Saudi Arabia. Methods: This was a 6-month cross-sectional study conducted from January to June 2016 at the critical care unit of HMG involving adult patients. The critical care unit has 30 beds dedicated to the treatment of trauma, medical, surgical and maternity patients. The clinical pharmacist monitors all patients through daily medical rounds and documents any intervention that needs to be provided to the patient. The pharmacist intervention system utilized an international study model, a measure of the level of activity, rational of clinical intervention, recommendation and patient outcome. Results: A total number of 1222 pharmacist interventions were provided to 1124 adult patients. The highest number of critical care interventions were found to be potentially significant (610 (49.9%)) followed by potentially serious (360 (29.5%)) and neutral (249 (20.4%)) cases. Anti-infective medications (185 (25.9%)) were the most category of intervention provided followed by cardiovascular medications (96 (13.5%)) and gastro-intestinal medications (73 (10.2%)). The documented rationale of clinical intervention activities was others (203 (28.7%)), inappropriate dose (122 (17.3%)) and therapeutic duplication ((99 (14%)). Most of the patient outcomes were unknown (539 (44.1%)) followed by patient condition improved (408 (33.4%)) and therapeutic endpoint reached (133 (10.9%)). Conclusion: The clinical pharmacy services at critical care units of a private hospital is a significant and essential component for patients care. The clinical pharmacist prevents the occurrence of drug-related problems in addition to saving additional economic burden on the healthcare system at HMG in the Kingdom of Saudi Arabia.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.